Study: NCT02123615

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For abdomen
Description: Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subdermally with ASIS Device for 30 patients.~Gadolinium For abdomen Total Persistent % subdermally on MRI at 6 hrs, 12 hrs, and 24 hrs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For abdomen
Description: Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subdermally with ASIS Device for 30 patients.~Gadolinium For abdomen Total Persistent % subdermally on MRI at 6 hrs, 12 hrs, and 24 hrs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For abdomen
Description: Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subcutaneously for 30 patients.~Gadolinium For abdomen Total Persistent % subcutaneously on MRI at 6 hrs, 12 hrs, and 24 hrs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For abdomen
Description: Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subcutaneously for 30 patients.~Gadolinium For abdomen Total Persistent % subcutaneously on MRI at 6 hrs, 12 hrs, and 24 hrs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For abdomen
Description: Gadolinium For abdomen Relative Prolongation Ability Score or total Persistent % of Gadolinium subdermally over total Persistent % of Gadolinium subcutaneously on MRI.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For abdomen
Description: Gadolinium For abdomen Relative Prolongation Ability Score or total Persistent % of Gadolinium subdermally over total Persistent % of Gadolinium subcutaneously on MRI.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For lower back
Description: Gadolinium For lower back Total Persistent % subdermally on MRI at 6 hrs, 12 hrs, and 24 hrs. Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subdermally with ASIS Device for 30 patients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For lower back
Description: Gadolinium For lower back Total Persistent % subdermally on MRI at 6 hrs, 12 hrs, and 24 hrs. Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subdermally with ASIS Device for 30 patients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For lower back
Description: Gadolinium For lower back Total cumulative Persistent % of Gadolinium subcutaneously on MRI at 6 hrs, 12 hrs, and 24 hrs. Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subcutaneously for 30 patients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For lower back
Description: Gadolinium For lower back Total cumulative Persistent % of Gadolinium subcutaneously on MRI at 6 hrs, 12 hrs, and 24 hrs. Gadolinium 1cc/ diluted with 19cc normal saline (for \<40kg) or 29cc normal saline (for \>40kg) subcutaneously for 30 patients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For lower back
Description: Gadolinium For lower back Relative Prolongation Ability Score or total Persistent % of Gadolinium subdermally over total Persistent % of Gadolinium subcutaneously on MRI .

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium For lower back
Description: Gadolinium For lower back Relative Prolongation Ability Score or total Persistent % of Gadolinium subdermally over total Persistent % of Gadolinium subcutaneously on MRI .

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 12
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 12.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: subjects (%) with Days out of work as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with Days out of work as Efficacy of Gammagard subcutaneously at Week 24

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: (%) with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 24
Description: Annual rate with hospitalized infections as Efficacy of Gammagard subcutaneously at Week 24.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: Annual rate of any infections as Efficacy of Gammagard subcutaneously at Week 36.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efficacy of Gammagard subcutaneously at Week 36
Description: subjects (%) with Antibiotic use as Efficacy of Gammagard subcutaneously at Week 36.